GlassScriptPhysician profile
John A Coccaro
NPI 1235280314
$17,115.78
in general payments reported to CMS, 2019-2025
26 companies · $2,084 in 2025
The $2,084 reported for 2025 was more than what 79% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,825 · 2020: $1,030 · 2021: $2,981 · 2022: $1,525 · 2023: $2,123 · 2024: $2,546 · 2025: $2,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,703 · Travel and Lodging: $1,630 · Education: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,702.91 |
| Travel and Lodging | $1,630.14 |
| Education | $421.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,858.54 | 2019-2023 | Senza |
| Boston Scientific Corporation | $3,071.07 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, General - Therapies |
| Medtronic, INC. | $1,994.29 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Saluda Medical Americas, INC. | $1,649.34 | 2023-2025 | Evoke, Evoke Scs |
| Spinal Simplicity, LLC | $1,050.76 | 2025 | Ha Minuteman G3-R |
| Vertiflex, INC. | $942.68 | 2019 | |
| Vertos Medical, INC. | $755.67 | 2019-2024 | Mild Device Kit |
| Abbott Laboratories | $732.22 | 2019-2024 | Octrode |
| Si-Bone, INC. | $652.42 | 2020-2024 | |
| Medtronic USA, INC. | $316.11 | 2019 | |
| Nalu Medical, INC. | $230.21 | 2021-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $166.86 | 2022-2025 | Sprint Pns System |
| Biotronik Nro, INC. | $128.04 | 2024 | Prospera |
| Nuvasive, INC. | $112.17 | 2019 | |
| Foundation Fusion Solutions, LLC | $109.01 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $80.18 | 2019-2020 | |
| Providence Medical Technology, INC. | $67.84 | 2023 | |
| Bioventus LLC | $35.06 | 2024 | Durolane |
| Pacira Pharmaceuticals Incorporated | $34.74 | 2022 | |
| Stryker Corporation | $32.73 | 2025 | Optablate |
| Medline Industries LP | $23.35 | 2023 | |
| Fidia Pharma USA INC. | $16.96 | 2023 | Hymovis |
| Globus Medical, INC. | $16.61 | 2025 | Senza |
| Depuy Synthes Sales INC. | $15.78 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.70 | 2019 | |
| Painteq LLC | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Coccaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.